Showing results (1-10 of 319) with videos related to
Sort By:
Pageof 32
Nephron|September 28, 2016
Rituximab in Membranous Nephropathy: Not All Studies Are Created EqualPaolo CravediGiornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 22, 2012
[Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art]Paolo CravediNephron|April 2, 2019
Making Procurement Biopsies Important Again for Kidney Transplant AllocationAndrea Angeletti, Paolo CravediBritish Journal of Clinical Pharmacology|February 28, 2013
Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney diseasePaolo Cravedi, Giuseppe RemuzziNephron|May 21, 2019
Criteria for Living Donation from Marginal Donors: One, No One, and One Hundred ThousandChiara Cantarelli, Paolo CravediCurrent Opinion in Organ Transplantation|July 1, 2014
The marginal kidney donorUmberto Maggiore, Paolo CravediKidney International. Supplement|November 27, 2008
Treating the kidney to cure the heartPaolo Cravedi, Giuseppe RemuzziNefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 7, 2014
Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseasesJoaquín Manrique, Paolo CravediTransplantation|February 9, 2026
Updates on Kidney Transplantation From the World Transplant Congress 2025Johan Noble, Paolo CravediJournal of Nephrology|June 2, 2016
Monitoring alloimmune response in kidney transplantationOriol Bestard, Paolo CravediPageof 32